April 30th 2025
A seminar shares key observations and learnings from the first round of direct price negotiations.
Market access is about aligning internal strategies with external realities that often change without warning and at a frequency likely not experienced by other biopharma executive roles.
April 23rd 2025
CMS’ draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare coverage decisions.
April 17th 2025
Four tips for midsized companies when entering new global markets.
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.